Malignant Solid Neoplasm — Trials

Malignant Solid Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

900 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 429
Recruiting: 209
Ph III recruiting: 10
Growth YoY: +2.3%
Industry share: 21%
Top sponsor: National Cancer Institute (NCI)
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (101)

clinicaltrialsPublishedShowing 101–150 of 900 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06500377	Comparing the Impact of Four Types of Meditation Practices for Relaxation in Cancer Survivors	suspended	N/A	44	City of Hope Medical CenterOTHER	1	Sep 3, 2026	clinicaltrials
NCT06771739	A Pilot Unrestricted Payment Program for Early-stage Cancer Patients: the PAYMENT Trial	recruiting	N/A	20	Fred Hutchinson Cancer CenterOTHER	1	Sep 3, 2026	clinicaltrials